Versor Investments’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,798
| Closed | -$1.4M | – | 118 |
|
|
2025
Q4 | $1.4M | Sell |
6,798
-6,515
| -49% | -$1.23M | 0.22% | 83 |
|
|
2025
Q3 | $2.09M | Buy |
+13,313
| New | +$2.06M | 0.38% | 26 |
|
|
2024
Q4 | – | Sell |
-28,194
| Closed | -$3.12M | – | 773 |
|
|
2024
Q3 | $3.12M | Buy |
28,194
+23,722
| +530% | +$2.48M | 0.49% | 13 |
|
|
2024
Q2 | $440K | Sell |
4,472
-6,652
| -60% | -$678K | 0.08% | 391 |
|
|
2024
Q1 | $1.24M | Sell |
11,124
-1,348
| -11% | -$145K | 0.25% | 91 |
|
|
2023
Q4 | $1.26M | Sell |
12,472
-22,000
| -64% | -$2.18M | 0.26% | 84 |
|
|
2023
Q3 | $2.99M | Buy |
34,472
+14,600
| +73% | +$1.32M | 0.61% | 17 |
|
|
2023
Q2 | $1.88M | Sell |
19,872
-9,800
| -33% | -$828K | 0.33% | 25 |
|
|
2023
Q1 | $2.24M | Buy |
29,672
+4,900
| +20% | +$370K | 0.29% | 33 |
|
|
2022
Q4 | $1.9M | Sell |
24,772
-80,213
| -76% | -$6.09M | 0.16% | 46 |
|
|
2022
Q3 | $7M | Buy |
104,985
+33,813
| +48% | +$2.14M | 0.42% | 26 |
|
|
2022
Q2 | $3.72M | Buy |
71,172
+31,791
| +81% | +$1.81M | 0.14% | 41 |
|
|
2022
Q1 | $2.23M | Buy |
39,381
+7,864
| +25% | +$421K | 0.08% | 48 |
|
|
2021
Q4 | $1.62M | Buy |
31,517
+11,645
| +59% | +$571K | 0.05% | 61 |
|
|
2021
Q3 | $983K | Buy |
19,872
+9,100
| +84% | +$494K | 0.03% | 118 |
|
|
2021
Q2 | $615K | Sell |
10,772
-2,500
| -19% | -$146K | 0.02% | 121 |
|
|
2021
Q1 | $806K | Buy |
+13,272
| New | +$733K | 0.05% | 78 |
|
|
2020
Q4 | – | Sell |
-23,690
| Closed | -$1.11M | – | 134 |
|
|
2020
Q3 | $1.11M | Buy |
23,690
+16,100
| +212% | +$826K | 0.09% | 62 |
|
|
2020
Q2 | $396K | Buy |
+7,590
| New | +$391K | 0.04% | 106 |
|
|
2020
Q1 | – | Sell |
-6,299
| Closed | -$319K | – | 255 |
|
|
2019
Q4 | $319K | Sell |
6,299
-86,500
| -93% | -$4.47M | 0.02% | 264 |
|
|
2019
Q3 | $4.38M | Buy |
92,799
+30,400
| +49% | +$1.39M | 0.3% | 39 |
|
|
2019
Q2 | $2.94M | Buy |
62,399
+41,400
| +197% | +$1.91M | 0.2% | 73 |
|
|
2019
Q1 | $1.01M | Buy |
20,999
+6,771
| +48% | +$339K | 0.1% | 110 |
|
|
2018
Q4 | $635K | Buy |
14,228
+3,600
| +34% | +$188K | 0.15% | 131 |
|
|
2018
Q3 | $574K | Sell |
10,628
-3,972
| -27% | -$203K | 0.21% | 136 |
|
|
2018
Q2 | $713K | Buy |
+14,600
| New | +$828K | 0.24% | 128 |
|
Other funds holding CAH
VCM
VPM
Versor Investments's CAH Position: Q1 2026 in Review
Versor Investments sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 6,798 shares — an estimated $1.4M sold.
Versor Investments first reported a position in CAH in Q2 2018 and held it in 26 quarters. The position peaked at $7M in Q3 2022. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Versor Investments reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
- Versor Investments sold 6,798 Cardinal Health shares in Q1 2026, an estimated $1.4M.
- Versor Investments first reported a position in Cardinal Health in Q2 2018 and held it in 26 quarters.
- Versor Investments's Cardinal Health position peaked at $7M in Q3 2022.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.